19th DIA Japan Annual Meeting 2022

New “Quest for the future”~Moving Creativity and Innovation Forward in “New Normal”~

LS11 Model-Informed Drug Development: Application of MIDD to the Development of Novel Drugs for Treatment of COVID-19 Has Changed the World

Session Chair(s)

So Miyoshi

• Head of Clinical Pharmacology
• Japan

Speaker(s)

Akiyuki Suzuki, MS

• Senior Manager, Pharmacometrics Group, Clinical Pharmacology
• Pfizer Japan Inc., Japan

Tsuyoshi Shiga

• Associate Professor, Department of Cardiology
• Tokyo Women's Medical University, Japan

Daisuke Iwata

• Office of Advanced Evaluation with Electronic Data
• Pharmaceuticals and Medical Devices Agency, Japan